As the business world adopts a 24/7 timeframe, more companies are instituting controls that operate continuously. Talecris Biotherapeutics, a North Carolina-based maker of medical treatments, put in place a system that lets both business heads and the audit group keep tabs on controls.

The effort began as Talecris prepared to go public, a change that "meant that we needed to be able to focus everyone on controls," says Mary Ann Tourney, the company's senior director of internal audit. Given the audit department's size, automating testing of controls "would allow us time, with a small staff, to accomplish over 100 audit tests every week automatically, look at the results and engage the business process owners in looking at their own controls," Tourney says.

Talecris has two units: Talecris Biotherapeutics, which uses blood plasma to make treatments, and Talecris Plasma Resources, a chain of plasma collection centers.

Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.

  • Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Susan Kelly

Susan Kelly is a business journalist who has written for Treasury & Risk, FierceCFO, Global Finance, Financial Week, Bridge News and The Bond Buyer.